Enzalutamid Sandoz 40 mg

Enzalutamid Sandoz 40 mg is a medicine authorised by Swissmedic under authorisation number 69477. The authorisation holder is Sandoz Pharmaceuticals AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 28 May 2024 and the authorisation is limited until 27 May 2029. ATC code L02BB04 places the medicine in the group Endocrine therapy.

  • Dispensing category B
  • Authorisation number 69477
  • ATC L02BB04
  • Synthetic medicines
Authorisation data
Authorisation number69477
NameEnzalutamid Sandoz 40 mg
Full nameEnzalutamid Sandoz 40 mg, Filmtabletten
Authorisation holderSandoz Pharmaceuticals AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeL02BB04
First authorisation28 May 2024
Authorisation validity27 May 2029
Strengths
No.NameDispensing categoryAuthorisation date
1Enzalutamid Sandoz 40 mg, FilmtablettenB28 May 2024
2Enzalutamid Sandoz 80 mg, FilmtablettenB28 May 2024
3Enzalutamid Sandoz 160 mg, FilmtablettenB11 August 2026

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
1112Tablette(n)L02BB0407.16.2.B
256Tablette(n)L02BB0407.16.2.B
328Tablette(n)L02BB0407.16.2.B
456Tablette(n)L02BB0407.16.2.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Enzalutamid Sandoz 40 mg authorised in Switzerland?

Yes. Enzalutamid Sandoz 40 mg is authorised by Swissmedic under authorisation number 69477, data as of 01 September 2026. The authorisation is limited until 27 May 2029.

Which dispensing category does Enzalutamid Sandoz 40 mg have?

Enzalutamid Sandoz 40 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Enzalutamid Sandoz 40 mg?

The authorisation holder is Sandoz Pharmaceuticals AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com